Annual Interest Expense
$485.90 M
+$154.30 M+46.53%
31 December 2023
Summary:
Eli Lilly and Company annual interest expense is currently $485.90 million, with the most recent change of +$154.30 million (+46.53%) on 31 December 2023. During the last 3 years, it has risen by +$126.30 million (+35.12%). LLY annual interest expense is now at all-time high.LLY Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$192.70 M
+$9.10 M+4.96%
30 September 2024
Summary:
Eli Lilly and Company quarterly interest expense is currently $192.70 million, with the most recent change of +$9.10 million (+4.96%) on 30 September 2024. Over the past year, it has increased by +$68.10 million (+54.65%). LLY quarterly interest expense is now at all-time high.LLY Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$694.10 M
+$68.10 M+10.88%
30 September 2024
Summary:
Eli Lilly and Company TTM interest expense is currently $694.10 million, with the most recent change of +$68.10 million (+10.88%) on 30 September 2024. Over the past year, it has increased by +$262.40 million (+60.78%). LLY TTM interest expense is now at all-time high.LLY TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LLY Interest Expense Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +46.5% | +54.6% | +60.8% |
3 y3 years | +35.1% | +130.5% | +99.7% |
5 y5 years | +100.4% | +79.4% | +91.7% |
LLY Interest Expense High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +46.5% | at high | +137.3% | at high | +111.0% |
5 y | 5 years | at high | +100.4% | at high | +137.3% | at high | +111.0% |
alltime | all time | at high | +226.6% | at high | +442.8% | at high | +1060.7% |
Eli Lilly And Company Interest Expense History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $192.70 M(+5.0%) | $694.10 M(+10.9%) |
June 2024 | - | $183.60 M(+2.2%) | $626.00 M(+11.2%) |
Mar 2024 | - | $179.60 M(+30.0%) | $562.70 M(+15.8%) |
Dec 2023 | $485.90 M(+46.5%) | $138.20 M(+10.9%) | $485.90 M(+12.6%) |
Sept 2023 | - | $124.60 M(+3.6%) | $431.70 M(+11.1%) |
June 2023 | - | $120.30 M(+17.0%) | $388.60 M(+11.2%) |
Mar 2023 | - | $102.80 M(+22.4%) | $349.50 M(+5.4%) |
Dec 2022 | $331.60 M(-2.4%) | $84.00 M(+3.1%) | $331.60 M(+0.8%) |
Sept 2022 | - | $81.50 M(+0.4%) | $329.00 M(-0.6%) |
June 2022 | - | $81.20 M(-4.4%) | $331.10 M(-1.7%) |
Mar 2022 | - | $84.90 M(+4.3%) | $336.80 M(-0.9%) |
Dec 2021 | $339.80 M(-5.5%) | $81.40 M(-2.6%) | $339.70 M(-2.2%) |
Sept 2021 | - | $83.60 M(-3.8%) | $347.50 M(-1.7%) |
June 2021 | - | $86.90 M(-1.0%) | $353.50 M(-0.4%) |
Mar 2021 | - | $87.80 M(-1.6%) | $354.90 M(-1.3%) |
Dec 2020 | $359.60 M(-10.2%) | $89.20 M(-0.4%) | $359.60 M(-1.8%) |
Sept 2020 | - | $89.60 M(+1.5%) | $366.30 M(-4.6%) |
June 2020 | - | $88.30 M(-4.5%) | $384.10 M(-5.6%) |
Mar 2020 | - | $92.50 M(-3.5%) | $406.70 M(+1.5%) |
Dec 2019 | $400.60 M(+65.2%) | $95.90 M(-10.7%) | $400.70 M(+10.7%) |
Sept 2019 | - | $107.40 M(-3.2%) | $362.00 M(+14.8%) |
June 2019 | - | $110.90 M(+28.2%) | $315.40 M(+17.8%) |
Mar 2019 | - | $86.50 M(+51.2%) | $267.80 M(+10.4%) |
Dec 2018 | $242.50 M(+7.8%) | $57.20 M(-5.9%) | $242.50 M(-2.3%) |
Sept 2018 | - | $60.80 M(-3.9%) | $248.20 M(-0.4%) |
June 2018 | - | $63.30 M(+3.4%) | $249.30 M(+4.0%) |
Mar 2018 | - | $61.20 M(-2.7%) | $239.60 M(+6.5%) |
Dec 2017 | $225.00 M(+21.5%) | $62.90 M(+1.6%) | $225.00 M(+5.4%) |
Sept 2017 | - | $61.90 M(+15.5%) | $213.50 M(+7.4%) |
June 2017 | - | $53.60 M(+15.0%) | $198.80 M(+5.5%) |
Mar 2017 | - | $46.60 M(-9.3%) | $188.40 M(+1.7%) |
Dec 2016 | $185.20 M | $51.40 M(+8.9%) | $185.20 M(+4.0%) |
Sept 2016 | - | $47.20 M(+9.3%) | $178.00 M(+4.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2016 | - | $43.20 M(-0.5%) | $170.10 M(+3.9%) |
Mar 2016 | - | $43.40 M(-1.8%) | $163.70 M(+1.6%) |
Dec 2015 | $161.20 M(+8.3%) | $44.20 M(+12.5%) | $161.20 M(+4.4%) |
Sept 2015 | - | $39.30 M(+6.8%) | $154.40 M(+0.8%) |
June 2015 | - | $36.80 M(-10.0%) | $153.20 M(+0.9%) |
Mar 2015 | - | $40.90 M(+9.4%) | $151.90 M(+2.1%) |
Dec 2014 | $148.80 M(-7.1%) | $37.40 M(-1.8%) | $148.80 M(-1.5%) |
Sept 2014 | - | $38.10 M(+7.3%) | $151.10 M(-1.1%) |
June 2014 | - | $35.50 M(-6.1%) | $152.80 M(-3.0%) |
Mar 2014 | - | $37.80 M(-4.8%) | $157.60 M(-1.6%) |
Dec 2013 | $160.10 M(-10.0%) | $39.70 M(-0.3%) | $160.10 M(-1.7%) |
Sept 2013 | - | $39.80 M(-1.2%) | $162.90 M(-4.2%) |
June 2013 | - | $40.30 M(0.0%) | $170.10 M(-1.6%) |
Mar 2013 | - | $40.30 M(-5.2%) | $172.80 M(-2.8%) |
Dec 2012 | $177.80 M(-4.4%) | $42.50 M(-9.6%) | $177.80 M(-4.1%) |
Sept 2012 | - | $47.00 M(+9.3%) | $185.40 M(+1.1%) |
June 2012 | - | $43.00 M(-5.1%) | $183.40 M(-1.1%) |
Mar 2012 | - | $45.30 M(-9.6%) | $185.50 M(-0.3%) |
Dec 2011 | $186.00 M(+0.3%) | $50.10 M(+11.3%) | $186.00 M(+3.9%) |
Sept 2011 | - | $45.00 M(-0.2%) | $179.10 M(-1.2%) |
June 2011 | - | $45.10 M(-1.5%) | $181.30 M(-1.3%) |
Mar 2011 | - | $45.80 M(+6.0%) | $183.70 M(-1.0%) |
Dec 2010 | $185.50 M(-29.0%) | $43.20 M(-8.5%) | $185.50 M(-3.6%) |
Sept 2010 | - | $47.20 M(-0.6%) | $192.50 M(-5.9%) |
June 2010 | - | $47.50 M(-0.2%) | $204.50 M(-7.6%) |
Mar 2010 | - | $47.60 M(-5.2%) | $221.30 M(-15.3%) |
Dec 2009 | $261.30 M(+14.5%) | $50.20 M(-15.2%) | $261.30 M(-10.8%) |
Sept 2009 | - | $59.20 M(-7.9%) | $293.00 M(+5.5%) |
June 2009 | - | $64.30 M(-26.6%) | $277.80 M(+8.5%) |
Mar 2009 | - | $87.60 M(+7.0%) | $256.10 M(+12.2%) |
Dec 2008 | $228.30 M | $81.90 M(+86.1%) | $228.30 M(+55.9%) |
Sept 2008 | - | $44.00 M(+3.3%) | $146.40 M(+43.0%) |
June 2008 | - | $42.60 M(-28.8%) | $102.40 M(+71.2%) |
Mar 2008 | - | $59.80 M | $59.80 M |
FAQ
- What is Eli Lilly and Company annual interest expense?
- What is the all time high annual interest expense for Eli Lilly and Company?
- What is Eli Lilly and Company annual interest expense year-on-year change?
- What is Eli Lilly and Company quarterly interest expense?
- What is the all time high quarterly interest expense for Eli Lilly and Company?
- What is Eli Lilly and Company quarterly interest expense year-on-year change?
- What is Eli Lilly and Company TTM interest expense?
- What is the all time high TTM interest expense for Eli Lilly and Company?
- What is Eli Lilly and Company TTM interest expense year-on-year change?
What is Eli Lilly and Company annual interest expense?
The current annual interest expense of LLY is $485.90 M
What is the all time high annual interest expense for Eli Lilly and Company?
Eli Lilly and Company all-time high annual interest expense is $485.90 M
What is Eli Lilly and Company annual interest expense year-on-year change?
Over the past year, LLY annual interest expense has changed by +$154.30 M (+46.53%)
What is Eli Lilly and Company quarterly interest expense?
The current quarterly interest expense of LLY is $192.70 M
What is the all time high quarterly interest expense for Eli Lilly and Company?
Eli Lilly and Company all-time high quarterly interest expense is $192.70 M
What is Eli Lilly and Company quarterly interest expense year-on-year change?
Over the past year, LLY quarterly interest expense has changed by +$68.10 M (+54.65%)
What is Eli Lilly and Company TTM interest expense?
The current TTM interest expense of LLY is $694.10 M
What is the all time high TTM interest expense for Eli Lilly and Company?
Eli Lilly and Company all-time high TTM interest expense is $694.10 M
What is Eli Lilly and Company TTM interest expense year-on-year change?
Over the past year, LLY TTM interest expense has changed by +$262.40 M (+60.78%)